All Stories

Mineralys' stock jumps as hypertension drug posts double clinical wins

Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension.

Mar 11, 2025 - 14:07
 0
Mineralys' stock jumps as hypertension drug posts double clinical wins
Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension.
Read More

Tags:

Previous Article

Tales From the Beat Episode 97-Two-Way Vet Eric Mayne

Next Article

Life sciences preprint servers have grown up — and are setting out on their own

Related Posts

ElevateBio gene therapy lowers levels of toxic protein in mice with Huntington’s disease

ElevateBio gene therapy lowers levels of toxic protein ...

Feb 28, 2025  0

Harbour offshoot pens $395M biobucks deal for preclinical rival to Neurocrine’s Crenessity

Harbour offshoot pens $395M biobucks deal for preclinic...

Feb 26, 2025  0

US judge blocks Trump administration from cutting NIH grants amid ongoing litigation

US judge blocks Trump administration from cutting NIH g...

Mar 5, 2025  0